Pituicytoma

Pituicytoma is an extremely rare, low-grade (WHO grade I) primary neoplasm of the sellar region that arises from pituicytes, the specialized glial cells of the neurohypophysis (posterior pituitary gland) and infundibulum (pituitary stalk). It is classified among spindle cell oncocytic tumors of the posterior pituitary and is considered a benign tumor, though it can cause significant symptoms due to its location. Pituicytoma is sometimes referred to as posterior pituitary astrocytoma or infundibuloma in older literature. The tumor primarily affects the endocrine and neurological systems. As it grows within the sella turcica, it can compress the anterior pituitary gland, optic chiasm, and surrounding structures. Key clinical features include visual disturbances (particularly visual field defects such as bitemporal hemianopia), headaches, and hypopituitarism resulting from compression of the normal pituitary gland. Some patients may also develop hyperprolactinemia due to pituitary stalk compression (stalk effect), and rarely, diabetes insipidus may occur. The tumor typically presents as a solid, well-circumscribed, highly vascular mass on imaging, which can make it difficult to distinguish from pituitary adenomas preoperatively. The primary treatment for pituicytoma is surgical resection, typically via a transsphenoidal approach. A notable surgical consideration is the tumor's high vascularity, which can lead to significant intraoperative bleeding. Gross total resection is the goal and is often curative, with generally favorable long-term outcomes. However, subtotal resection may be necessary when the tumor is adherent to critical neurovascular structures, and recurrence can occur in such cases. The role of adjuvant radiation therapy remains uncertain due to the rarity of the tumor, but it may be considered for recurrent or incompletely resected tumors. Long-term follow-up with serial MRI imaging and endocrine evaluation is recommended. There is no established chemotherapy regimen for this tumor.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly

Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest

Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)

Source: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months

Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC

Common questions about Pituicytoma